<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">radhyd</journal-id><journal-title-group><journal-title xml:lang="ru">Радиационная гигиена</journal-title><trans-title-group xml:lang="en"><trans-title>Radiatsionnaya Gygiena = Radiation Hygiene</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1998-426X</issn><issn pub-type="epub">2409-9082</issn><publisher><publisher-name>NIIRG</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21514/1998-426X-2026-19-1-63-71</article-id><article-id custom-type="elpub" pub-id-type="custom">radhyd-1285</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>Оценка радиопротекторного потенциала фумаровой кислоты, фумарата 3–гидроксипиридина и деанола ацеглумата при действии γ–излучения, протонов и ионов 12C на клетки человека</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of the radioprotective potential of fumaric acid, 3-hydroxypyridine fumarate and deanol aceglumate under the action of γ-radiation, protons and 12C ions on human cells</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1298-920X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Купцова</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuptsova</surname><given-names>P. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Купцова Полина Сергеевна – старший преподаватель Отделения биотехнологий.</p><p>249039, Калужская область, городской округ «Город Обнинск», город Обнинск, тер. Студгородок, д. 1</p></bio><bio xml:lang="en"><p>Polina S. Kuptsova – Senior Lecturer at the Department of Biotechnology.</p><p>1, Studgorodok, Obninsk, Kaluga Region, 249040</p></bio><email xlink:type="simple">kuptsova_apollinaria@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0491-4486</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комарова</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Komarova</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Комарова Людмила Николаевна – доктор биологических наук, профессор Отделения биотехнологий.</p><p>Обнинск</p></bio><bio xml:lang="en"><p>Lyudmila N. Komarova – Doctor of Biological Sciences, Professor of the Department of Biotechnology.</p><p>Obninsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8055-9239</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ольховая</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Olkhovaya</surname><given-names>E. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольховая Елена Романовна – заведующая учебно-научной лабораторией Отделения биотехнологий.</p><p>Обнинск</p></bio><bio xml:lang="en"><p>Elena R. Olkhovaya– Head of the Educational and Scientific Laboratory of the Department of Biotechnology.</p><p>Obninsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-5738-8478</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лапенко</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Lapenko</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лапенко Алина Константиновна – специалист по учебно-методической работе Отделения биотехнологий.</p><p>Обнинск</p></bio><bio xml:lang="en"><p>Alina K. Lapenko – Specialist in Educational and Methodological Work of the Department of Biotechnology.</p><p>Obninsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-0572-9427</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шкавров</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shkavrov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шкавров Сергей Владимирович – кандидат химических наук, заместитель начальника Фармацевтического центра практического обучения и компетенций, доцент Отделения биотехнологий.</p><p>Обнинск</p></bio><bio xml:lang="en"><p>Sergey V. Shkavrov – Candidate of Chemical Sciences, Deputy Head of the Pharmaceutical Center for Practical Training and Competencies, Associate Professor of the Department of Biotechnology.</p><p>Obninsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9891-6740</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Купцов</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuptsov</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Купцов Илья Сергеевич – кандидат физико-математических наук, доцент кафедры общей и специальной физики.</p><p>Обнинск</p></bio><bio xml:lang="en"><p>Ilya S. Kuptsov – Candidate of Physical and Mathematical Sciences, Associate Professor of the Department of General and Special Physics.</p><p>Obninsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6907-2753</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сабуров</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Saburov</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сабуров Вячеслав Олегович – заведующий лабораторией разработки и эксплуатации облучающей техники.</p><p>Обнинск</p></bio><bio xml:lang="en"><p>Vyacheslav O. Saburov – Head of the Laboratory for Development and Operation of Irradiation Equipment.</p><p>Obninsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Обнинский институт атомной энергетики — филиал Национального исследовательского ядерного университета «МИФИ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Obninsk Institute for Nuclear Power Engineering</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Медицинский радиологический научный центр им. А.Ф. Цыба – филиал Национального медицинского исследовательского центра радиологии Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A. Tsyb National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>01</day><month>04</month><year>2026</year></pub-date><volume>19</volume><issue>1</issue><fpage>63</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Купцова П.С., Комарова Л.Н., Ольховая Е.Р., Лапенко А.К., Шкавров С.В., Купцов И.С., Сабуров В.О., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Купцова П.С., Комарова Л.Н., Ольховая Е.Р., Лапенко А.К., Шкавров С.В., Купцов И.С., Сабуров В.О.</copyright-holder><copyright-holder xml:lang="en">Kuptsova P.S., Komarova L.N., Olkhovaya E.R., Lapenko A.K., Shkavrov S.V., Kuptsov I.S., Saburov V.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.radhyg.ru/jour/article/view/1285">https://www.radhyg.ru/jour/article/view/1285</self-uri><abstract><p>Актуальность исследования новых радиопротекторов обусловлена потребностью в защите здоровых тканей при лучевой терапии. Существующие препараты имеют серьёзные побочные эффекты, что требует поиска более безопасных и эффективных аналогов.</p><p>Цель работы – сравнительный анализ радиопротекторной эффективности трех перспективных соединений – фумаровой кислоты, фумарата 3-гидроксипиридина и деанола ацеглумата в условиях in vitro. Задачи: определить нетоксичные концентрации соединений, оценить их защитное действие при разных типах излучения (γ-кванты, протоны, ионы 12C), сравнить влияние на нормальные (фибробласты Фб-hTERT) и опухолевые (нейробластома SK-N-BE(2)) клетки.</p><sec><title>Материалы и методы</title><p>Материалы и методы: Исследование проводилось на культурах клеток под воздействием ионизирующих излучений разного качества: гамма-квантов (60Co), протонов и ускоренных ионов 12C. Установлены оптимальные концентрации: фумаровая кислота – 400 мкМ, фумарат 3-гидроксипиридина – 200 мкМ, деанола ацеглумат – 1000 мкМ. Время инкубации – 24 часа.</p><p>Результаты исследования и обсуждение: Показано, что все соединения проявили значимый радиозащитный эффект при γ-облучении (1–12 Гр) для фибробластов, на опухолевые клетки также наблюдалось защитное действие. При облучении протонами и ионами 12C радиопротекторный эффект отсутствовал. Деанола ацеглумат продемонстрировал наибольшую эффективность.</p></sec><sec><title>Заключение</title><p>Заключение: Таким образом, исследование подтвердило перспективность деанола ацеглумата и других соединений как радиопротекторов при γ-облучении. Их применение может снизить повреждение здоровых тканей при лучевой терапии. Однако для протонов и тяжёлых ионов защитный эффект не выявлен, что требует дальнейшего изучения.</p></sec></abstract><trans-abstract xml:lang="en"><p>The relevance of the research of new radioprotectors is due to the need to protect healthy tissues during radiation therapy. Existing drugs have serious side effects, which requires the search for safer and more effective analogues.</p><p>The aim of the work is a comparative analysis of the radioprotective efficacy of three promising compounds – fumaric acid, 3-hydroxypyridine fumarate and deanol aceglumate in vitro. Tasks: to determine non-toxic concentrations of compounds, to evaluate their protective effect under different types of radiation (gamma quanta, protons, 12C ions), to compare the effect on normal (fibroblasts Fb-hTERT) and tumor (neuroblastoma SK-N-BE(2)) cells.</p><sec><title>Materials and Methods</title><p>Materials and Methods: the study was conducted on cultures of cells under the influence of ionizing radiation of different quality: gamma quanta (60Co), protons and accelerated 12C ions. Optimal concentrations have been established: fumaric acid – 400 μmol, 3-hydroxypyridine fumarate – 200 μmol, deanol aceglumate – 1000 μmol. Incubation time is 24 hours.</p></sec><sec><title>Results and Discussion</title><p>Results and Discussion: It was shown that all compounds showed a significant radioprotective effect on gamma radiation (1-12 Gy) for fibroblasts; the protective effect was also observed on tumor cells. There was no radioprotective effect when irradiated with protons and 12C ions. Deanol aceglumate has demonstrated the greatest effectiveness.</p></sec><sec><title>Conclusion</title><p>Conclusion: The study confirmed the prospects of deanol aceglumate and other compounds as radioprotectors under gamma irradiation. Their use can reduce damage to healthy tissues during radiation therapy. However, no protective effect has been detected for protons and heavy ions, which requires further study.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>радиопротекторы</kwd><kwd>гамма-излучение</kwd><kwd>ионы 12C</kwd><kwd>протоны</kwd><kwd>фумаровая кислота</kwd><kwd>фумарат 3-гидроксипиридина</kwd><kwd>деанола ацеглумат</kwd></kwd-group><kwd-group xml:lang="en"><kwd>radioprotectors</kwd><kwd>gamma radiation</kwd><kwd>12C ions</kwd><kwd>protons</kwd><kwd>fumaric acid</kwd><kwd>3-hydroxypyridine fumarate</kwd><kwd>deanol aceglumate</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Публикация не имела финансовой поддержки</funding-statement><funding-statement xml:lang="en">The study was not financially supported</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ferlay J., Colombet M., Soerjomataram I. et al. Cancer statistics for the year 2020: An overview // International Journal of Cancer. 2021. Vol. 149, No. 4. P. 778–789. DOI: 10.1002/ijc.33588.</mixed-citation><mixed-citation xml:lang="en">Kaprin AD, Starinsky VV, Shakhzadova AO. State of cancer care for the population of Russia in 2023. Moscow: P.A. Herzen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 2024. 262 p. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gardner S.J., Kim J., Chetty I.J. Modern Radiation Therapy Planning and Delivery // Hematology/Oncology Clinics of</mixed-citation><mixed-citation xml:lang="en">Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. International journal of cancer. 2021;149(4): 778789. DOI: 10.1002/ijc.33588.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">North America. 2019. Vol. 33, No. 6. P. 947-962. DOI: 10.1016/j.hoc.2019.08.005.</mixed-citation><mixed-citation xml:lang="en">Gardner SJ, Kim J, Chetty IJ. Modern Radiation Therapy Planning and Delivery. Hematology/Oncology Clinics of North America. 2019;33(6): 947-62. DOI: 10.1016/j.hoc.2019.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson D., Chen Y., Ahmad S. Dose and linear energy transfer distributions of primary and secondary particles in carbon ion radiation therapy: A Monte Carlo simulation study in water // Journal of medical physics. 2015. Vol. 40, No. 4. P. 214–219. DOI: 10.4103/0971-6203.170785.</mixed-citation><mixed-citation xml:lang="en">Johnson D, Chen Y, Ahmad S. Dose and linear energy transfer distributions of primary and secondary particles in carbon ion radiation therapy: A Monte Carlo simulation study in water. Journal of Medical Physics. 2015;40(4): 214-219. DOI: 10.4103/0971-6203.170785.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Гребенюк А.Н., Легеза В.И., Миляев А.В. и др. Современная стратегия защитных и медицинских мероприятий при радиационных авариях // Радиационная гигиена. 2018. Т. 11, № 4. С. 80-88.</mixed-citation><mixed-citation xml:lang="en">Grebenyuk AN, Legeza VI, Milyaev AV, Starkov AV. Modern strategy of health protection and medical measures in radiation accidents. Radiatsionnaya Gygiena = Radiation Hygiene. 2018;11(4): 80-88. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mun G. I., Kim S., Choi М. et al. Pharmacology of natural radioprotectors // Archives of Pharmacal Research. 2018. Vol. 16, № 11. P. 1033-1050.</mixed-citation><mixed-citation xml:lang="en">Mun GI, Kim S, Choi M, Kim CS, Lee YS. Pharmacology of natural radioprotectors. Archives of pharmacal research. 2018;41(11): 1033-1050.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Abdollahi H., Shiri I., Atashzar M. et al. Radiation protection and secondary cancer prevention using biological radioprotectors in radiotherapy // International Journal of Cancer Therapy and Oncology. 2015. Vol. 29. URL: https://doi.org/10.20935/AcadNano7267 (Дата обращения: 24.11.2024).</mixed-citation><mixed-citation xml:lang="en">Abdollahi H, Shiri I, Atashzar M, Sarebani M, Moloudi K, Samadian H. Radiation protection and secondary cancer prevention using biological radioprotectors in radiotherapy. International Journal of Cancer Therapy and Oncology. 2015;3(1). Available from: https://doi.org/10.20935/AcadNano7267 [Accessed 24 Nov 2024].</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shivappa P., Bernhardt G.V. Natural Radioprotectors on Current and Future Perspectives: A Mini-Review // Journal of Pharmacy &amp; Bioallied Sciences. 2022. Vol. 14. P. 57-71.</mixed-citation><mixed-citation xml:lang="en">Shivappa P, Bernhardt GV. Natural Radioprotectors on Current and Future Perspectives: A Mini-Review. Journal of pharmacy &amp; bioallied sciences. 2022;14(1): 57-71.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Joiner M., Kogel van der. Basic Clinical Radiobiology. 4th ed. London: Hodder Arnold, 2009. 375 p.</mixed-citation><mixed-citation xml:lang="en">Joiner M, van der Kogel A. Basic Clinical Radiobiology. 4th ed. London: Hodder Arnold; 2009. 375 p.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Radioprotectors. org: an open database of known and predicted radioprotectors. URL: https://radioprotectors.org/home (Дата обращения: 13.11.2024).</mixed-citation><mixed-citation xml:lang="en">Radioprotectors. org: an open database of known and predicted radioprotectors. Available from: https://radioprotectors.org/hom e [Accessed 13 Nov 2024].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ilica R.A., Kloetzer L., Galaction A.I., Caşcaval D. Fumaric acid: production and separation // Biotechnology letters. 2019. Vol. 41, No. 1. P. 47–57. DOI: 10.1007/s10529-018-2628-y.</mixed-citation><mixed-citation xml:lang="en">Ilica RA, Kloetzer L, Galaction AI, Caşcaval D. Fumaric acid: production and separation. Biotechnology Letters. 2019;41(1): 47-57. DOI: 10.1007/s10529-018-2628-y.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wipke B.T., Hoepner R., Strassburger-Krogias K. et al. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses // Neurology(R) neuroimmunology &amp; neuroinflammation. 2021. Vol. 8, No. 2. DOI: 10.1212/NXI.0000000000000950.</mixed-citation><mixed-citation xml:lang="en">Wipke BT, Hoepner R, Strassburger-Krogias K, Thomas AM, Gianni D, Szak S, et al. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses. Neurology(R) neuroimmunology &amp; neuroinflammation. 2021;8(2): e950. DOI: 10.1212/NXI.0000000000000950.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Volc-Platzer B. Fumaric acid esters for paediatric psoriasis // The British journal of dermatology. 2021. Vol. 185, No. 1. P. 5–6. DOI: 10.1111/bjd.20057.</mixed-citation><mixed-citation xml:lang="en">Volc-Platzer B. Fumaric acid esters for paediatric psoriasis. British Journal of Dermatology. 2021;185(1): 5-6. DOI: 10.1111/bjd.20057.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Коршунова А.Б., Костычев Н.А., Инчина В.И., Чаиркин И.Н. Перспективы фармакологической коррекции острой ишемии головного мозга // Известия Самарского научного центра Российской академии наук. 2009. Т. 11, № 1. С. 1287-1290.</mixed-citation><mixed-citation xml:lang="en">Korshunova AB, Kostychev NA, Inchina VI, Chairkin IN. Prospects for pharmacological correction of acute cerebral ischemia. Izvestiya Samarskogo nauchnogo tsentra Rossiyskoy akademii nauk = Bulletin of the Samara Scientific Center of the Russian Academy of Sciences. 2009;11(1): 1287-1290. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Сайт «Соль 2-этил-6-метил-3-гидроксипиридина с фумаровой кислотой, обладающая метаболической и кардиопротекторной активностью, и способ ее получения». URL: https://patents.google.com/patent/RU2365582C1/ru (Дата обращения: 19.06.2025).</mixed-citation><mixed-citation xml:lang="en">Salt of 2-ethyl-6-methyl-3-hydroxypyridine with fumaric acid, possessing metabolic and cardioprotective activity, and method for its preparation Available from: https://patents.google.com/patent/RU2365582C1/ru [Accessed 19 Jun 2025]. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Выпова Е. Р., Купцова П.С., Комарова Л.Н. и др. Исследование возможных радиопротекторных свойств деанола ацеглумата при действии ионизирующего излучения на клетки человека // Радиация и риск (Бюллетень НРЭР). 2023. Т. 32, № 3. С. 38-49.</mixed-citation><mixed-citation xml:lang="en">Vypova ER, Kuptsova PS, Komarova LN, Berseneva AA, Baldov DA, Kotlyarov AA. Study of possible radioprotective properties of deanol aceglumate under the action of ionizing radiation on human cells. Radiatsiya i risk = Radiation and Risk. 2023;32(3): 38-49. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Носков Д.С., Поройков В.В., Ших Е.В. и др. Деанола ацеглумат (нооклерин): клинико-фармакологические аспекты и актуальность применения в лечебной практике // Журнал неврологии и психиатрии им. С.С. Корсакова. 2013. № 113. С. 97-99.</mixed-citation><mixed-citation xml:lang="en">Noskov DS, Poroikov VV, Shikh EV, Iasnetsov VV. Deanol aceglumate (Nooclerin): clinical and pharmacological aspects and relevance of use in medical practice. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113: 97-99. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Чутко Л.С., Сурушкина С.Ю., Никишена И.С. и др. Применение деанола ацеглумата при лечении неврастении у подростков со школьной дезадаптацией // Вопросы современной педиатрии. 2013. Т. 12, № 5. С. 99-103.</mixed-citation><mixed-citation xml:lang="en">Chutko LS, Surushkina SYu, Nikishena IS, Yakovenko EA, Anisimova TI. The use of deanol aceglumate in the treatment of neurasthenia in adolescents with school maladjustment. Voprosy sovremennoy pediatrii = Problems of Modern Pediatrics. 2013;12(5): 99-103. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Прилепский А.Ю., Дроздов А.С., Богатырев В.А., Староверов С.А. Методы работы с клеточными культурами и определение токсичности наноматериалов. СПб: Университет ИТМО, 2019. 43 с.</mixed-citation><mixed-citation xml:lang="en">Prilepskiy AYu, Drozdov AS, Bogatyrev VA, Staroverov SA. Methods of working with cell cultures and determining the toxicity of nanomaterials. Saint Petersburg: ITMO University; 2019. 43 p. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Храмченкова О.М. Основы радиобиологии: учебное пособие для студентов биологических специальностей высших учебных заведений. Гомель: УО «ГГУ им. Ф. Скорины», 2003. 238 с.</mixed-citation><mixed-citation xml:lang="en">Khramchenkova OM. Fundamentals of Radiobiology: a textbook for students of biological specialties of higher educational institutions. Gomel: Educational Institution «GSU named after. F. Skorina»; 2003. 238 p. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Купцова П.С., Комарова Л.Н., Выпова Е.Р. Исследование радиопротекторных свойств фумаровой кислоты и фумарата 3-оксипиридина при действии ионизирующего излучения на клетки человека // Радиационная гигиена. 2023. Т. 16, № 1. С. 32-39.</mixed-citation><mixed-citation xml:lang="en">Kuptsova PS, Komarova LN, Vypova ER. Study of radioprotective properties of fumaric acid and 3-oxypyridine fumarate under the action of ionizing radiation on human cells. Radiatsionnaya Gygiena = Radiation Hygiene. 2023;16(1): 32-39. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Penabei S., Meesungnoen J., Jay-Gerin J.-P. Assessment of Cystamine’s Radioprotective Antioxidant Ability under HighDose-Rate Irradiation: A Monte Carlo Multi-Track Chemistry Simulation Study // Antioxidants. 2023. Vol. 12. P. 77-89.</mixed-citation><mixed-citation xml:lang="en">Penabei S, Meesungnoen J, Jay-Gerin JP. Assessment of Cystamine’s Radioprotective Antioxidant Ability under HighDose-Rate Irradiation: A Monte Carlo Multi-Track Chemistry Simulation Study. Antioxidants (Basel). 2023;12(1): 77. DOI: 10.3390/antiox12010077.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Thoene J., Gavin R.F., Towne A. et al. In vitro activity of cysteamine against SARS-CoV-2 variants // Molecular Genetics and Metabolism. 2022. Vol. 137, № 1-2. P. 192–200.</mixed-citation><mixed-citation xml:lang="en">Thoene J, Gavin RF, Towne A, Wattay L, Ferrari MG, Navarrete J, et al. In vitro activity of cysteamine against SARS-CoV-2 variants. Molecular Genetics and Metabolism. 2022;137(12): 192-200. DOI: 10.1016/j.ymgme.2022.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Baumann M., Krause M., Overgaard J. et al. Radiation oncology in the era of precision medicine // Nature Reviews Cancer. 2008. Vol. 16, № 4. P. 234-249.</mixed-citation><mixed-citation xml:lang="en">Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J, et al. Radiation oncology in the era of precision medicine. Nature reviews. Cancer. 2016;16(4): 234-249. DOI: 10.1038/nrc.2016.18.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation // Science. 2009. Vol. 324, № 5930. P. 1029-1033.</mixed-citation><mixed-citation xml:lang="en">Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930): 1029-1033. DOI: 10.1126/science.1160809.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
